TCCPY yields 2.09% · MRK yields 2.81%● Live data
📍 TCCPY pulled ahead of the other in Year 3
Combined, TCCPY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TCCPY + MRK for your $10,000?
TechnoPro Holdings, Inc., through its subsidiaries, operates as a technology-focused staffing and services company in Japan and internationally. The company offers various services, including engineer staffing, contract assignment, engineering consulting, domestic nearshore and overseas offshore delivery, job placement, and education and training in the machinery, electrics and electronics, embedded controls, information systems, IT infrastructure, software development and maintenance, civil engineering, production plant, architecture, chemistry, biotechnology, and construction areas. It also provides IT system integration and package products; application development and IT consulting services; assessment, inspection, design, and supervision services of buildings; employment services for people with disabilities; and education and training services for CAD, programming, network construction, web design, PC operation, Microsoft office, etc. In addition, the company offers engineering consultancy and offshore development services; and recruitment process outsourcing services, as well as operates as a recruitment agency. TechnoPro Holdings, Inc. was formerly known as Prompt Holdings, Inc. and changed its name to TechnoPro Holdings, Inc. in April 2013. The company was founded in 1995 and is headquartered in Tokyo, Japan.
Full TCCPY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.